News

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...
The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...
Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...
Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...
Johnson & Johnson (JNJ) has reportedly revised its forecast of the impact of U.S. President Donald Trump’s tariffs to $200 ...
President Donald Trump announced new tariffs on imports from the European Union (EU) and Mexico, aiming to improve trade ...
Ireland, with a major pharmaceutical industry, is in the front line along with Germany, for whom the United States is a major ...
India-US trade relations face significant challenges due to President Donald Trump's unpredictable tariff policies, which ...
W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...